Barosense Raises $27.4M

Redwood City-based Barosense, a developer of obesity treatments, has nabbed $27.4M as part of an ongoing $30.5M Series D round. No details on the funding have been announce, however, the firm is backed by Delphi Ventures, Frazier Healthcare Ventures, Invesco Private Capital, RWI Ventures, Synergy Life Science Partners, Wharton Ventures, and Pappas Ventures. PE Hub said Pappas Ventures is a new investor in the round. More information »